Market Overview
The Global Digital Pathology Market is expected to reach a value of
USD 1.1 billion in 2023, and it is further anticipated to reach a market value of
USD 2.2 billion by 2032 at a
CAGR of 8.0%.
Digital pathology includes the use of digital imaging technology in the field of pathology, as it depends on computer workstations to examine high-resolution digital whole slide images (WSIs) produced by scanning glass microscope slides, which finds applications in research, teaching, & primary diagnostic reporting, allowing healthcare professionals to analyze & interpret pathology samples more effectively & efficiently.
The latest news in digital pathology includes key events such as the Pathology Visions Conference hosted by the Digital Pathology Association in Orlando from November 3-5, 2024. This event showcases over 50 presenters and more than 70 posters, featuring innovations in digital pathology and AI applications. It's a major gathering for industry experts, offering networking opportunities and the latest advancements in patient care technology.
Additionally, the Digital Pathology & AI Congress will be held globally throughout 2024, with locations in Asia, Europe, and the USA. This congress focuses on the integration of AI and whole-slide imaging in pathology
As per the Drug Discovery & Development, the Digital Pathology market has experienced rapid adoption, with annual growth rates ranging from 27% to 37% between 2021 and 2023, driven by pandemic-induced urgency. While growth has tempered, momentum remains strong. Proscia's 2023 Life Sciences Digital Pathology Adoption Survey indicates that 70% of life sciences organizations had adopted digital pathology, with 53% of non-adopters planning implementation by year-end.
Additionally, 82% of adopters reported active use of the technology. The survey, which included insights from 40 executives spanning CROs and leading pharmaceutical companies, underscores digital pathology's pivotal role in modern drug discovery and development.
Market Dynamic
The rapid evolution of digital pathology systems is anticipated to be a driving force behind market expansion. Innovations in computerization, digital imaging, robotic light microscopy, & fiber optic communications are all contributing to this growth. In addition, whole slide imaging is emerging as a technique with several advantages over traditional light microscopes, which is anticipated to further boost the market.
In addition, the growth in the use of
artificial intelligence (AI) in healthcare, mainly for pathological diagnosis, is improving patient care quality & workflow efficiency, allowing healthcare professionals to aim at more critical cases. These AI solutions in healthcare are becoming increasingly user-friendly and human-centered.
However, the high cost of digital pathology & the limited adoption in emerging & underdeveloped regions are potential obstacles to market growth. To address this, strategies like modularity & integrated software applications in hardware platforms are assisting in keeping the costs of digital pathology manageable while expanding its accessibility.
Research Scope and Analysis
By Product
The device segment seizes the largest market share in 2023 & is anticipated to experience significant growth in the coming future, as it comprises slide management systems & scanners, and its dominance can be said owing to the growing integration of digital pathology into academic research endeavors, supported by improved image resolution.
Also, the software segment is expected to notice a rapid growth rate during the forecasted period, whose growth is primarily driven by the rise in the incidence of cancer cases, allowing major industry players to invest in the development of innovative digital pathology systems. These software solutions play a major role in enhancing diagnostic & research capabilities within the field.
By Application
In 2023, the academic research segment takes the lead in the market & is expected to maintain its dominant position throughout the forecast period, which is mainly due to the ongoing research endeavors aiming at advancing cancer therapies & the growing adoption of digital pathology in several research projects. Many academic research institutes are partnering with digital pathology providers to integrate this technology into their research activities.
Moreover, disease diagnosis is expected to notice the most rapid growth rate in the coming years, which is attributed to the growth in the prevalence of chronic diseases & the manufacturers' growing emphasis on developing rapid & innovative diagnostic techniques to facilitate the seamless exchange of information between departments. The adoption of digital technologies plays a major role in improving the efficiency of disease diagnosis, ultimately leading to enhanced therapeutic outcomes.
By End User
The dominant factor in the global digital pathology market is the hospital segment. Hospitals have become the go-to choice for disease diagnosis &
healthcare. The constant developments in hospital laboratories are important to meet the changing demands of patients, as more & more hospitals are looking to offer a comprehensive range of services in-house.
Many hospitals are including digital scanning techniques to improve patient adherence & accelerate the diagnostic process. Also, the diagnostic labs segment is anticipated to have the fastest growth rate during the forecasted period, which can be attributed to the growing emphasis on drug development, preclinical GLP pathology, &
clinical trials in oncology. In addition, the rise in the number of
cancer & the adoption of digital pathology within diagnostic labs are driving the market's growth in this sector.
The Digital Pathology Market Report is segmented on the basis of the following:
By Product
- Device
- Software
- Storage System
By Application
- Academic Research
- Disease Diagnosis
- Drug Discovery & Development
By End User
- Hospitals
- Diagnostic Labs
- Biotech & Pharma Companies
- Academic & Research Institutes
Regional Analysis
North America leads in the global digital pathology market
with a substantial 42.2% share in 2023, which is primarily due to the region's proactive government initiatives that drive the development of advanced pathology technologies.
Continuous investments in R&D, a growing adoption of digital imaging, & the presence of key industry players in the area further contribute to its dominance. In addition, the growth in the use of digital pathology in academic research & disease diagnosis is fueling the regional market's expansion.
Further, the Asia Pacific region is anticipated to have rapid growth during the forecasted period, which can be attributed to the region's rapid digitalization, growing investments in the medical field, & a rise in the number of digital imaging in emerging economies. Moreover, a higher incidence of cancer cases in the region is increasing the demand for innovative treatment solutions, thereby further propelling market growth in the Asia Pacific.
By Region
North America
Europe
- Germany
- The U.K.
- France
- Italy
- Russia
- Spain
- Benelux
- Nordic
- Rest of Europe
Asia-Pacific
- China
- Japan
- South Korea
- India
- ANZ
- ASEAN
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of Latin America
Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Egypt
- Rest of MEA
Competitive Landscape
The digital pathology market is dominated by a small number of companies with a strong global & regional presence, resulting in a concentrated industry structure, as the competitive landscape involves an examination of both international & local firms that possess significant market shares, influencing the overall dynamics of the sector.
For instance, in March 2023, Leica Biosystems revealed its expanded collaboration with Paige, focusing on supported by AI & image management technologies within global digital pathology workflows, which looks to advance the capabilities of digital pathology systems globally by leveraging Paige's expertise, potentially improving the analysis & management of medical images through artificial intelligence, ultimately benefitting the medical community & patient care.
Some of the prominent players in the global Digital Pathology Market are:
- 3DHistech Ltd
- Mikroscan Technologies Inc
- Nikon Corp
- Sectra AG
- XIFIN Inc
- Olympus Corp
- Proscia Inc
- Inspirata Inc
- Leica Biosystem
- Visiopharm A/S
- Other Key Players
COVID-19 Pandemic & Recession: Impact on the Global Digital Pathology Market:
The COVID-19 pandemic had a high impact on the global digital pathology market. As the healthcare system faced intense pressure, the need for remote diagnostic solutions increased, leading to a growth in demand for digital pathology technologies. These systems enabled pathologists to look into tissue samples from a distance, lowering the risk of exposure to the virus & allowing quicker diagnoses.
In addition, the recession that came with the pandemic led to cost-saving measures in healthcare, making digital pathology an attractive option due to its potential for efficiency & cost reduction. As a result, the global digital pathology market experienced significant growth during this period, driven by the emergency necessity for remote diagnostic capabilities & the economic considerations of healthcare providers.
| Report Characteristics |
| Market Size (2023) |
USD 1.1 Bn |
| Forecast Value (2032) |
USD 2.2 Bn |
| CAGR (2023-2032) |
8.0% |
| Historical Data |
2017 - 2022 |
| Forecast Data |
2023 - 2032 |
| Base Year |
2022 |
| Estimate Year |
2023 |
| Report Coverage |
Market Revenue Estimation, Market Dynamics, Competitive Landscape, Growth Factors and etc. |
| Segments Covered |
By Product (Device, Software, and Storage System),
By Application (Academic Research, Disease
Diagnosis, and Drug Discovery & Development), By
End User (Hospitals, Diagnostic Labs, Biotech &
Pharma Companies, and Academic & Research
Institutes) |
| Regional Coverage |
North America – The US and Canada; Europe – Germany, The UK, France, Russia, Spain, Italy, Benelux, Nordic, & Rest of Europe; Asia- Pacific– China, Japan, South Korea, India, ANZ, ASEAN, Rest of APAC; Latin America – Brazil, Mexico, Argentina, Colombia, Rest of Latin America; Middle East & Africa – Saudi Arabia, UAE, South Africa, Turkey, Egypt, Israel, & Rest of MEA
|
| Prominent Players |
3DHistech Ltd, Mikroscan Technologies Inc, Nikon
Corp, Sectra AG, XIFIN Inc, Olympus Corp, Proscia Inc,
Inspirata Inc, Leica Biosystem, Visiopharm A/S, and
Other Key Players |
| Purchase Options |
We have three licenses to opt for: Single User License (Limited to 1 user), Multi-User License (Up to 5 Users), and Corporate Use License (Unlimited User) along with free report customization equivalent to 0 analyst working days, 3 analysts working days and 5 analysts working days respectively. |
Frequently Asked Questions
The Global Digital Pathology Market size is estimated to have a value of USD 1.1 billion in 2023 and is
expected to reach USD 2.2 billion by the end of 2032.
North America has the largest market share for the Global Digital Pathology Market with a share of
about 42.2% in 2023.
Some of the major key players in the Global Digital Pathology Market are Nestle, PepsiCo Inc, Danone,
Nikon Corp, 3DHistech Ltd, Lecia Biosystems, and many others.
The market is growing at a CAGR of 8.0 % over the forecasted period.